求助7篇文献 不胜感激

aaaszw

7 g' Z7 o5 W+ X% q3 [, L& y
6 S% _; y) y" M: b' y7 PTumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.
* m! ?8 n; i( Z  a. Ghttps://www.ncbi.nlm.nih.gov/pubmed/27912061  B; K- l& m& B$ F1 }' _

* |* l1 U6 {( ]! GThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
, C0 _) x9 O/ e  s" O: S, Chttps://www.ncbi.nlm.nih.gov/pubmed/27525555- T. V) S7 F6 i* u% q1 [# c

# P$ l) j" m! C1 _6 zBioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion% S$ N: I: x6 `, A2 H$ e
https://www.ncbi.nlm.nih.gov/pubmed/27496729! _" C7 O8 d: U
4 f- A8 M5 T( R8 k2 V  |* u, Z
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.# E/ w1 I. f0 N& R# t8 P
https://www.ncbi.nlm.nih.gov/pubmed/274307221 K3 K) D8 M0 R: u" J: N3 I

9 M, [; W) P& S8 zCostimulatory and Coinhibitory Receptor Pathways in Infectious Disease.5 N% F$ B2 A7 c: r' O
https://www.ncbi.nlm.nih.gov/pubmed/271925691 [, [8 h% v$ j2 m) R

0 P) l$ h" `! s5 [; ^( V" QCombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
0 U* ]# F( h% z- S- xhttps://www.ncbi.nlm.nih.gov/pubmed/27058661
1 o5 u2 D  z7 q, d* Y% _2 H/ q. K  r
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
2 k0 _1 l0 k+ f( khttps://www.ncbi.nlm.nih.gov/pubmed/27036972

aaaszw

回复 lchanlon 的帖子
1 \; C4 \5 ?& Y  [. ~  `! u7 V+ x7 w1 F, I- u
merci beaucoup ：）

lchanlon

回复 aaaszw 的帖子, j  C7 [  Y5 D! E
, ~; }7 `* ~! Y( V1 j* K. }& r
Here you go ) G9 D! {0 P/ ?7 n2 J. w* M
5 \4 _& A( p5 o; h2 t
Good luck!

lchanlon

回复 aaaszw 的帖子, B5 F0 A& i9 ^

; l3 d" m3 S1 A% t; G( HHere you go
2 U, r2 E! K" ]$ y* K+ e8 k. Q9 o
4 y7 i; C  H) f/ MGood luck!